Language selection

Search

Patent 2174942 Summary

Third-party information liability

Some of the information on this Web page has been provided by external sources. The Government of Canada is not responsible for the accuracy, reliability or currency of the information supplied by external sources. Users wishing to rely upon this information should consult directly with the source of the information. Content provided by external sources is not subject to official languages, privacy and accessibility requirements.

Claims and Abstract availability

Any discrepancies in the text and image of the Claims and Abstract are due to differing posting times. Text of the Claims and Abstract are posted:

  • At the time the application is open to public inspection;
  • At the time of issue of the patent (grant).
(12) Patent Application: (11) CA 2174942
(54) English Title: NUCLEOSIDE ANALOGUE METHOD
(54) French Title: PROCEDE DE PRODUCTION D'UN ANALOGUE DE NUCLEOSIDE
Status: Deemed Abandoned and Beyond the Period of Reinstatement - Pending Response to Notice of Disregarded Communication
Bibliographic Data
(51) International Patent Classification (IPC):
  • C12P 19/30 (2006.01)
(72) Inventors :
  • SMITH, CLIFFORD (United Kingdom)
  • FULLER, CARL (United States of America)
(73) Owners :
  • AMERSHAM INTERNATIONAL PLC
(71) Applicants :
  • AMERSHAM INTERNATIONAL PLC (United Kingdom)
(74) Agent: KIRBY EADES GALE BAKER
(74) Associate agent:
(45) Issued:
(86) PCT Filing Date: 1994-12-01
(87) Open to Public Inspection: 1995-06-08
Examination requested: 2001-11-27
Availability of licence: N/A
Dedicated to the Public: N/A
(25) Language of filing: English

Patent Cooperation Treaty (PCT): Yes
(86) PCT Filing Number: PCT/GB1994/002630
(87) International Publication Number: GB1994002630
(85) National Entry: 1996-04-24

(30) Application Priority Data:
Application No. Country/Territory Date
93309597.8 (European Patent Office (EPO)) 1993-12-01

Abstracts

English Abstract


A method of making a dideoxynucleoside mono- or tri-phosphate, which is optionally 32-P or 33-P or 35-5 radiolabelled, involves
reacting the corresponding dideoxynucleoside with an optionally radiolabelled nucleotide phosphate or thiophosphate donor in the presence
of a kinase or phosphotranferase enzyme which catalyses the reaction. A method of sequencing nucleic acids by a chain termination
technique involves detecting the products of enzymatic synthesis by means of isotopically labelled chain terminating nucleotide analogues.


French Abstract

Un procédé de production d'un mono- ou triphosphate didésoxynucléosidique, qui est éventuellement radiomarqué 32-P ou 33-P ou 35-S, consiste à faire réagir le didésoxynucléoside correspondant avec un doneur de phosphate ou thiophosphate nucléotidique éventuellement radiomarqué en présence d'une kinase ou phosphotransférase qui catalyse la réaction. Un procédé de séquençage d'acides nucléiques, effectué à l'aide d'une technique de terminaison en chaîne, consiste à détecter les produits de synthèse enzymatique au moyen d'analogues nucléotidiques de terminaison de chaîne, marqués isotopiquement.

Claims

Note: Claims are shown in the official language in which they were submitted.


- 20 -
CLAIMS
1. A method of making a nucleotide or nucleotide
analogue or nucleotide adduct, having a 5' -phosphate or
a 5' -thiophosphate group which method comprises
reacting a starting nucleoside or nucleoside analogue
or nucleoside adduct having a 5 ' -OH group but no 3' -
phosphate group, with a nucleotide phosphate or
thiophosphate donor in the presence of an enzyme which
catalyses the reaction
2. A method as claimed in claim 1, wherein the
nucleotide phosphate or thiophosphate donor is
ra-diolabelled with 32p or 33P or 35S, whereby the
obtained nucleotide or nucleotide analogue or
nucleotide adduct is radiolabelled by virtue of having
a 5'-phosphate or 5'-thiophosphate group comprising 32p
or 33P or 35S
3. A method as claimed in claim 1 or claim 2,
wherein the starting nucleo6ide analogue is a 2', 3' -
dideoxynucleoside.
4. A method as claimed in claim 1 or claim 2,
wherein the starting nucleoside analogue is a 3' -
fluoro, 3' -amino, or 3' =azido nucleoside, or is PNA or
an anti-sense oligonucleotide.
5. A method as claimed in any one of claims 1 to
4, wherein the enzyme is a polynucleotide kinase.
6. A method as claimed in any one of claims 1 to
5, wherein the reaction is performed at 4-30°C and
pH 4-9.
7. A method as claimed in any one of claims 1 to
6, wherein the nucleotide phosphate or thiophosphate
donor is [gamma32P] ATP or [gamma35S] ATP or
[gamma 33P] ATP.

-21-
8. A method as claimed in any one of claims 1 to 7, wherein a
2'-3'-dideoxynucleoside is reacted with [gamma32P] ATP to make a 5'-32p
nucleoside phosphate.
9. A method as claimed in claim 8, wherein the 5'-32p nucleoside
monophosphate is subsequently converted to the di- or tri-phosphate.
10. A method as claimed in any one of claims 1 to 4, wherein the
enzyme is a phosphotransferase enzyme derived from barley seedlings.
11. A kit for sequencing nucleic acids, which kit comprises or
includes a supply of each of the four chain terminating nucleotides or
nucleotide analogues labelled with a radioisotope.
12. A kit as claimed in claim 11, wherein the chain terminating
nucleotide analogues are dideoxynucleotides.
13. A kit as claimed in claim 11 or claim 12 wherein each of the
four chain terminating nucleotide analogues is labelled with 32p or 33P or
35S.
14. A kit as claimed in any one of claims 11 to 13, wherein the kit
includes also a supply of a polymerase enzyme and a supply of each of the
four dNTPs.
15. A kit as claimed in claim 14, wherein the polymerase enzyme
is a T7 DNA polymerase and the kit includes also a buffer containing Mn2+.
16. A method of sequencing a nucleic acid by a chain-temmination
technique, which method comprises effecting template-directed enzymatic
synthesis using as a chain terminator a nucleotide or nucleotide analogue
labelled with a radioisotope and detecting products of enzymatic synthesis
by means of the radioisotope.
17. A method as claimed in claim 16, wherein the enzymatic
synthesis reaction is performed using a T7 DNA polymerase enzyme in the
presence of all four dNTPs and of the labelled chain terminating nucleotide
or nucleotide analogue in a buffer containing Mn-.

- 22 -
18. A method as claimed in claim 16 or claim 17, wherein the
radioisotope is 32p or 33P or 35S.
19. ddCTP and ddGTP and ddTTP which is radiolabelled by 32p
or 33P or 35S.
20. ddCTP and ddGTP and ddTTP as claimed in claim 19
wherein the radiolabel is present in an .alpha.-phosphate group.

Description

Note: Descriptions are shown in the official language in which they were submitted.


Wo 9~rls395 2 1 7 ~ 9 4 2 ~
N~rCLEOSIDE ~T~r-f~r~ OD
[~32p] dideoxy~ nl-Rin~triphosphate is
commercially available. The current chemical
production method i9 very inef f icient . This invention
provides an enzymatic method of preparation, which
10 improves efficiency. The method is applicable to a
wide range of compounds besides this one.
T4 polynucleotide kinase (T4 PNK) is usually
associated with the phosphorylation of the 5 ~ -OX group
of an oligonucleotide, DNA or 2-deoxynucleoside-3-
15 monophosphate (or ribo) by transfer of the gamma-
phosphate group from ATP. (Analytical Biochemistry
214, 338-340, 1993). It is generally believed that for
T4 PNK to phosphorylate the 5 ' -OH group of a
nucleotide, the nucleotide must contain a 5 ' -OH and a
20 3 ' -phosphate group. Because the 3 ' -phosphate group is
clearly absent from 2 ', 3 ' -dideoxynucleosides and other
known chain terminators, the use of T4 PNK to catalyse
their phosphorylation has hitherto been considered
impossible. This inYentiOn results from our surprising
25 discovery that T4 P~rK can be used to catalyse this
reaction. The invention covers tlle use of T4 PNK and
other enzyme8 to catalyse this and related reactions.
Known kits for sequencing nucleic acids
comprise supplies of all four nucleotides, and supplies
3o of all four 2',3~-dideoxynucleotides, and a supply of
one nucleotide which has been labelled, generally
radioactively labelled, to permit detection of the
products after sequencing by electrophoresis. In
another aspect, this invention is based on the
35 realisation that improved results can be obtained by
radiolabelling the dideoxynucleotides.

wo ss/1~3ss r~ 0
74q4~ - 2 -
Kit8 rr~nt~inin3 iluorescently labelled chain
terminators (ddNTPs) are known but isotopically
labelled ddNTPs have structures which are less likely
to interfere with polymerase activity, gel mobility and
do not require sophisticated equipment f or detection .
In one aspect, this invention provides a
method of making a nucleotide or nucleotide analogue or
nucleotide adduct, having a 51 -phosphate or a 51-
thiophosphate group which method comprises reacting a
starting nucleoside or nucleoside analogue or
nucleoside adduct having a 5 ' -OH group }:ut no 31-
phosphate group with a nucleotide phosphate or
thiophosphate donor in the presence of an en~yme which
catalyses the reaction. The nucleoside can be an
unmodif ied ribo or deoxyribonucleoside e . g .
deoxyadenosine .
It is possible that the nucleoside,
nucleoside analogue or nucleoside adduct may be non-
labelled and that the phosphate donor is also non-
labelled. This produces the corresponding nucleotide
without the need to use chemical phosphorylating
agents which may be damaging to the starting material
in some circumstances.
Alternatively the nucleoside can be labelled
with a detectable isotope e.g. a radioisotope such as
for example 3H or l4C and then converted to the
corr~psn~l; n~ labelled nucleotide with a non-labelled
phosphate donor or thiophosphate donor.
Preferably the nucleotide phosphate or
thiophosphate donor is radiolabelled with a detectable
isotope e.g. a radioactive isotope such as 32p or 33P
or 35S, whereby the obtained nucleotide or nucleotide
analogue or nucleotide adduct is radiolabelled by
virtue of having a 5 ' -phosphate or 5 ' -thiophosphate
3 5 group compri s ing 3 2 p or 3 3 P or 3 5S
The term nucleoside analogue ref ers to a

WO95~15395 2,1 7494~ r~ ..s ~ O
-- 3
compound which is aimilar to a nucleoside and i5
capable of perf orming at least some of the biochemical
functions of a nucleoside, and includes r ~ s and
multimers. There follows a non-exhaustive list of
5 nucleoside analogues.
Base M~ f ~ ral tiona
2 -aminoadenosine
5 -bromocytosine
5-methylcytosine
5 - ( 1 -propynyl ) cytosine
5 ~ propynyl ) uracil
5 -aminoallyluracil
s-;lm;nn:=l ]yluracil-"label"
1 5 thiouracil/thiothymine/thioguanine
aziridene derivatives
Sug~ r M.~; f ~ ration8
2 ~ -0-alkyl (e.g. allyl or methyl)
2 o 2 ' - f luoro
2 ~ -amino
2 ~ -deoxy
3 ' -deoxy
3 ~ label "
3 ' - f luoro
3 ~ -amino
3 ' -azido
2 ~, 3 ~ -unsaturated
30 Combinations of base and sugar ';fi~ation3
Phosphate Modi_ications
Pho6phorothioate
Phosphorodithioate
Hydrogen phosphonate
Methyl phosphonate
Phosphotriester

WO 95/15395 1 ~ O
211~94~ --
-- 4
Phosphoramidite
Methylene bridge derivatives
Modified bsr~kh/~n~
Polyamide nucleic acid (PNA) modified to give
the equivalent of a 5 ' hydroxyl, e . g . having the
f ormula
HO.CH2.CH2 .NCH2.CH2 .NH~CO.CH2.NCH2 .CH2 .NH}
CO . CH2 . Base CO . CH2 . Base
(For polyamide nucleic acids (PNA) see P. B.
Neilsen, Science Volume 254, 6 December 1991, Reports
pages 1497-1500) . Anti-sense and anti-gene
oligonucleotides provide another example of nucleoside
analogues .
he preferred and most important nucleoside
analogues with which the invention is concerned are the
four 2 ', 3 ' -dideoxynucleosides ddA, ddC, ddG and ddT.
The term nucleoside adduct refers to a
compound which results from the interaction between
reactive entities and DNA or RNA. Such reactive
entities include carcinogenic compounds or their
metabolites and free radicals generated by
electromagnetic rA~ t;~-n. High sensitivity detection
of nucleoside adducts is of great importance in the
evaluation of e.~o~,u~ ~ of organisms to agents which
modify nucleic acids. Examples of nucleoside adducts
include the reaction products of polycyclic aromatic
hydrocarbons (PAH) at N2 of guanosine, aromatic amines
and oxygen radicals at C8 of guanosine, of alkylating
3o agents at N7 and 06 of guanosine, and of mycotoxins at
N7 of g~lAn~-sinP.
A preferred enzyme for use in the method is a
polynucleotide kinase enzyme (PNK) such as T4
polynucleotide kinase. This enzyme is widely used in
the preparation of 32p 5 ' -dNMP, under standard reaction
conditions of 37C at pH 8.5, by a reaction which
_ _ _ ~ _ .. , , , , . . ... ,, . ... . ,, . _ _ _ _

Wo95115395 2 ~ 7 ' ~ 2 ~ 'fi';
-- 5 --
involves the phosphorylation of 3 ' -dNMP with [gamma32P] -
ATP and PNK. The inventors attempt to phosphorylate
2 ', 3 ' -dideoxyadenosine (which lacks 3 ' -phosphate) with
[gamma32P] ATP, using this enzyme and the3e reaction
conditions, was not successful. Success can
surprisingly however be achieved using lower
temperature and/or lower pH conditions The preferred
temperature range is 4-30C with 18 to 30C being more
preferred. The preferred pX range is 4 . 0-9 . 0 . A high
salt content, e.g. up to 150 mM NaCl, may be useful to
promote the desired reaction. Incubation of the
reactants under these conditions for times ranging from
10 minutes to 24 hours can give rise to good yields
which increase with longer reaction times. The use of
phosphatase free T4 PNK in which the 3 ' phosphatase
activity has been substantially removed may be
advantageous in eliminating side reactions which reduce
the nucleoside monophosphate yields.
Another enzyme that can be used in the method
of the invention is a phosphotransferase enzyme
extracted from barley seedlings (J. Biol. Chem., 257,
No. 9, pp 4931-9, 1982) . The enzyme has two
activities: one is the phosphotrans~erase which will
transier the phosphate irom a nucleoside-5 ~ -
~,ph~ ~phate to the 5 ' -hydroxyl group of any other
nucleoside, with a preference for purine
deoxynucleoside ~hAsph~te acceptors. The enzyme has
not, BO far as is known, been previously used in
phosphorylating 2 ~, 3 ' -dideoxynucleosides . The other
activity of this enzyme is that the phosphoryl-enzyme
inte" ~ te can transfer the phosphate to water rather
than the nucleoside acceptor, creating inorganic
phosphate. It is possible to control the enzyme
activity by varying pH, the ratio o~ donor to acceptor,
and the addition of salts to remove the water available
to the enzyme. Preferred conditions of use are 5 to
_ _ _ _

WO 95/15395 4 q ,~ ~ - 6 - , ~
30C at pH 4 to 9, particularly 7 to 8.5. The method
requires the introduction of 5 ' -NMP which is then used
a6 the phosphate donor. 5 ' -UMP i8 the preferred
5 ' -NMP.
Yet another phosphotransferase enzyme is
derived from calf thymus.
A nucleotide analogue is a nucleoside
analogue that has at least one 5 ~ -phosphate or 5 ' -
thiophosphate group.
Nucleotide phosphate and thiophosphate donors
are well known in the field. Preferred examples of
nucleotide phosphate donors are ATP, 5 ' -UMP,
ATP-gammaS, 5 ' -I/MP-~S. These donors may be
radiolabelled with 32p, 33p and 35S so that the label
transfers with a phosphate or thiophosphate group to
the nucleoside analogue . A pref erred nucleotide
phr.sph~te donor is [gamma32P] ATP. Reaction of this
donor with a 2 ', 3 ' -dideoxynucleoside, using PNK, gives
rise to a 5 ~ [~32P] nucleoside monophosphate.
These nucleoside monophosphates can be
readily and efficiently converted by known means to the
corresponding triphosphate. By the use of 33P or 35S,
the corresponding [~33P] or [~35S] dideoxynucleoside
triphosphates can be made.
When using an enzyme to phosphorylate a
nucleoside, it has been usual and useful to provide a
large excess of the chosen nucleotide phosphate (or
thiophosphate~ donor, which has the effect of pushing
the reaction in the desired direction. When the
nucleotide phosphate (or thiophosphate) donor is
radiolabelled, it is not practicable to provide a large
excess. As a result, the reaction conditions are more
critical if a good yield of a desired radiolabelled
nucleotide is to be obtained.
In another aspect, this invention provides a
kit for sequencing nucleic acids which kit comprises a
. . . . _ _ ... _ ... . . ... ... . _ _

2 ~ 749~2 . . .
-- 7 -
supply of each of the four chain terminating nucleotide or nucleotide
analogue labelled with a radoioisotope. Preferably the kit comprises [ct32p]
and/or [33P~ and/or [3Ss] chain l~ ld~ g nucleotide analogues e.g.
dideoxynucleoside triphosphates together with a polymerase enzyme e.g.
a T7 DNA polymerase, a supply of each of the four dNTPs and a bufler
containing Mn2'. The provision of the labelled ddNTPs should make their
use in sequencing reliable with improYed accuracy through reduced
background and more even band intensity.
In another aspect the invention provides a method of
o sequencing a nucleic acid by a chain-l~""i"dliun technique, which method
.,olll~,lib~s effecting.template-directed enzymatic synthesis using as a
chain It:""i"dlur a nucleotide or nucleotide analogue labelied with a
I;V;CUI. ~pe and detecting products of enzymatic synthesis by means of
the Iddiùisul~pe.
In yet another aspect, the invention provides any one of
ddCTP and ddGTP and ddTTP which is r~ hPIIP~ by 32p or 33P or 35S
wherein the radiolabel is preferably present in an -pll~a~JIldL~ group.
The detection of chain-~,,,,i,,dli~ll DNA sequencing products
after s~pardLivll by gel electrophoresis has been achieved in any of several
~o ways. The original methods involved the use of [_32p] dATP to internally-
label the newly-synthesised DNA. Similarly, r~inl~hPllP~ oligonucleotide
sequencing primers can also be used. More recently, primers and
rlllclPvti~Ps labelled with fluorescent dyes have also been used with
expensive, sensltive instruments which detect the fluorescent products.
75 These methods work well only if care is taken to ensure that all the DNA
chains are correctly terminated by dideoxy-nucleotides. Any chains which
terminate with deoxy-nucleotides at the 3' end may contribute to
background signal in the final electrophetogram. Such terminations can
occur when the polymerase is not highly processive or when the template
30 contains strong secondary structures. Such

wo 95/15~95 2 ~ 7 ~ 3 ~ 2 r ~ I, ~ ~ I ? A~ I
-- 8
non - specif ic stops are commonly seen in sequencing
experiments and usually re3ult in either errors or
require re-sequencing to correctly assign the affected
bases .
There have also been several successful
methods using fluorescent dyes attached to the chain-
terminating dideoxynucleotide (Prober et al Lee, L G,
Connell, C R, Woo, S L, Cheng, R D, McArdle, B F,
Fuller, C W, Halloran, N D & Wilson, R K, (1992),
Nucleic Acids Res., 20, 2471-2483. ~ These methods have
the advantage that the label is directly attached to
the molecule w~ich causes chain-termination. The false
or background terminations, when they occur, will not
be detected by the fluorescence-detection instrument.
here are two drawbacks to these methods. One is that
the dye-tagged dideoxynucleoside triphosphates are not
generally as efficient substrates for DNA polymerases
as non-tagged dideoxynucleotides. They must be used at
relatively high concentrations, and their rates of
reaction vary with local sequence context giving rise
to much les6 uniform band (or peak) intensities than
non- tagged nucleotides . The second is that the
equipment used to detect fluorescent-tagged DNA is
complex and expensive compared with the equipment
needed for traditional autoradiographic detection.
This invention f eatures the benef its of
placing the detectable label on the chain-terAlinating
nucleotide without the drawbacks of expensive detection
equipment or reduced reactivity with DNA polymerase.
This is done by tagging the chain-terminating
nucleotides with radioactive isotopes, especially of
sulphur or phosphorus. This requires the efficient
production of all four labelled dideoxynucleoside
triphosphates and also requires a workable method to
use them.
The original DNA polymerase used for chain-

21 7494~
W0 95115395 r~ 0
termination DNA sequencing (the large fragment of
DNA polymerase I or Klenow enzyme ) uses
dideoxynucleotides relatively; nPf f; r; Pnt ly . Most
sequencing methods using this polymerase require the
5 use of dideoxynucleotides at conce~trations up to 50 or
lOO times higher than the rrnrPntration of the
corresponding deoxynucleotide. Expressed as a
concentration ratio, ddNTP:dNTP is as high as lOO:l.
The typical minimum amount of dNTP for practical
10 sequencing is on the order of 30 pmol each to allow
extension of O . 5 pmol of primed template by an average
of 240 bases. Thus, 3000 pmol of ddNTP may be required
for sequencing with Klenow polymerase. The minimum
specific radioactivity for detection of extension
products from 0.5 pmol of template DNA with X-ray film
and overnight exposure is approximately 500 Ci/mol.
While this is practical for ordinary sequencing methods
with non-labelled ddNTPs, the high amounts required
make sequencing with 1 AhPl 1 P~l ddNTPs and this
20 polymerase prohibitively expensive, wasteful and
hazardous, requiring as much as l . 5 mCi per lane of
sequence .
A key feature of the new sequencing method is
the use of a DNA polymerase which efficiently uses
25 dideoxynucleoside triphosphates 80 that the
concentration ratio (and hence amount required) is
reduced to practical levels. One such polymerase is
modif ied T7 DNA polymerase when used in the presence of
Mn2+ (Tabor and Richardson, J. Biol. Chem. 264, 6447-
3o 6458). With this polymerase, dideoxynucleosidetriphosphates react almost as ef f iciently as
deoxynucleoside triphosphates, allowing the use of a
concentration ratio of ddNTP:dNTP of l:lOO. This ratio
is lO,OOO times more favourable for efficient use of
35 dideoxynucleotides than the ratio for Klenow
polymerase. With this polymerase and the amounts of
_ _ _ _ _ _ .

WO 95/15395
~ 7 494~ - lo -
template outlined above, as li~ctle as 0 . 3 pmol or
o.15 /lCi of labelled dideoxynucleoside triphosphate
will be required for each lane of the se~uencing
experiment. This amount i8 readily used economically
5 and 8af ely . Other DNA polymerase enzymes which make
efficient use of didoexynucleoside triphosphates can
also be used for this sequencing method.
An additional benef it when using modif ied T7
DNA polymerase and Mn2+ i5 the uniform band intensities
10 obtained. This makes interpretation o~ the sequencing
experiment more accurate.
The following examples illustrate the
invention .
15 T4 Polynucleotide Kinase = 5 ' -dephosphopolynucleotide
5 ' -phosphotransferase EC 2 . 7 .1. 78
Polynucleotide kinase 3 ' phosphatase free = 5 ~ -
dephosphopolynucleot ide 5 ' -phosphotrans f erase
EC 2 . 7 .1. 78 - from T4 am N81 pse T1 phage infected
E . coli BB
EXa~nD1e 1
3 . 5 /lmoles of each 2 ~, 3 ~ -dideoxynucleoside
(all four ba8es) were individually mixed with 50 units
of 3 ' -phosphatase free PNK and 5 nmoles of
[gamma32P] ATP in a buffer ~containing 50 mM Tris-HCl pH
7.5, 2.5 mM DTT and 30 mM Mg Acetate, 150 mM NaCl,
0.1 mM Spermine and 0.5 mM NH4Cl. The final reaction
volumes were 100 ~Ll and the reactions were incubated at
18C. The reactions were followed by TLC analysis on
PEI cellulose plates developed in 0 . 5 M LiCl and 1 M
formic acid.
Table 1 shows the Conversions to [32P]ddNMP's
with time.

WO 9S/1~395 ~ l 7 4 9 4 2 r~ o
Table 1
TIME % [32p] ddAMP r32P3 ddCMP ~ [32p~ ddGMP " [32p~ ddTMP
(minutes )
30 44.1 33.6 12.7 28.8
90 64 . 3 83 . 3 26 . 7 76 . 6
The TLC system was calibrated by using 32po4,
[32p] ddAMP ~produced chemically) and 5 ' d~MP as markers .
This enabled the TLC plates to be interpreted and the
peaks, obtained using a beta-particle scanner, identified.
Exa~le 2
The [32P] ddNMP products from Example 1 were
synthesised on a larger scale.
35 ~Lmoles of each 2 ', 3 ' -dideoxynucleoside
20 (all four bases) were individually mixed with 500 units
of 3 'phosphatase free PNK and 75 mCi (25 nmoles) of
[gamma32P] ATP in a buffer contai~ing 50 mM Tris-HCl
pH 7.5, 2.5 mM DTT, 30 mM Mg Acetate, 150 mM NaCl, 0.1
mM Spermine and 0 . 5 mM NH4Cl. The final reaction
25 volume6 were 2 ml and the reactions were incubated at
18C for 2 hours. The reactions were followed by TLC
analysis on PEI cellulose plates developed in 0 . 5 M
LiCl and l M formic acid.
Af ter 2 hours the reactions were stopped by
30 the addition of 2 ml absolute ethanol . Af ter
filtration the r~c~inn~ were purified by HPLC ion-
exchange chromatography . TLC analysis of the purif ied
r r~rhnqphates showed that the [32P]dd~MP tn~;n~-d
some inorganic 32po4. The other three monophosphates
35 all had purities in excess of 909~. The yields of the
reactions were of the same order as those seen in the
_ _ _ _ _

W0 95/15395 r~
2 1 7 ~ ~ 4 2 - 12 -
small scale assays in Table 1.
The [32p] dd~MP ' 5 were converted to the
respective [Q32P]ddNTP's readily and efficiently by
standard methods.
After purification by HPLC ion-exchange
chromatography the [132p] ddNTP ' 5 were resuspended at
-4 mCi/ml in aqueous solution. The final yields from
[gamma32P] ATP were:
ddATP 4 8 ~6
ddCTP 4 6 9s
ddGTP 15 9~
ddTTP 24~6
Samples were taken for identification by
analytical HPLC against the respective non-radioactive
ddNTP marker and for use in DNA sequencing . The
results showed that with all four ddNTP's the
radiolabelled [o!32p] ddNTP and the non-radioactive ddNTP
eluted from the HPLC column at exactly the same time.
Also in the absence of any other terminator or
radiolabel, apart from that synthe5ised above, the
sequence of an M13 template was successfully det~rm;n~d
when compared to the 6equence produced using
[Q35S] dATP i nt~rni~l label and non-radioactive ddNTP ' 8 .
This proves that the [~32p] ddNTP ' 8 were made
and therefore that PNK can, under these conditions,
phosphorylate 2 ', 3 ' -dideoxynucleosides .
ExamDle 3 BarleY See~ll ;n~ Pho.~ otLc~8~erRR~
O . 5 llmoles of uridine-5 ~ -l nphnsphate ~5 ' -
3o I~MP) was mixed individually with 0.5 llmoles of each
2 ', 3 ~ -dideoxynucleoside (except 2 ', 3 ' -ddG which was
O .15 ~Lmoles of 5 ' -I~MP and 2 ', 3 ' -ddG due to solubility
problems with 2 ', 3 ' -ddG - note still in 1:1 mole ratio)
and 10 1ll Barley Seedling Phosphotransferase (1.3
units/ml) in 50 mM Tris-HCl pH 7.5, 1 mM MgC12 and
O . 00296 Triton-100 . The final reaction volume was 50 ~Ll
.. ... . . ~ . = = .. , _ . _ . = _ . . , .. ~ .... .,, ., . ,, _ . .. .

2174 4
WO 95/ls39s 9 2 r ~ ;'ZO
- 13 -
.
and the reaction was incubated at 25C for 4 hours. 15
samples were removed for analysis by ion-exchange
chromatography, the samples were made up to 120 /11 with
water prior to loading. Analysi3 by this method showed
5 that all 4 base 2 ~ ,3 ~ -dideoxy nucleoside-5 ~ -
monophosphate6 had been successfully made.
A second experiment, this time using 5 ' -~MP
spiked with [32p] 5 ' -UMP, under the same conditions as
above except using a 5 ' -UMP: 2 ', 3 ' -dideoxyadenosine
mole ratio of 24:1, gave a radiolabelled peak of 2~,3~-
dideoxyadenosine-5 ~ -monophosphate on an analytical XPI,C
system which exactly matched that produced by the PNK
method. The HPLC system was calibrated using a mixture
of non-radioactive 5 ' -UMP and 5 ' -dAMP (no ddAMP
available commercially) . These were shown to be well
separated by the system with the 5 ' -di~MP running
slightly slower than the [32p] 2 ' ,3 ' -dideoxyadenosine-
5 ~ -monophosphate, which is to be expected on an ion-
exchange system due to the 3 ' -OH group. When this
reaction was repeated at pH 5 . O in 50 mM sodium acetate
buffer the HPI,C analysis revealed a very fast running
radiolabelled peak that was identified as inorganic
phosphate. This showed that the reaction is pH
~l~r~n~i~nt The addition of high r~nr~nt~ationS of salt
may also be beneficial and increase the yield of
monophosphate produced by inhibiting the production of
inorganic phosphate.
Exa~n~le 4 Secru~n~in~7 ProtoçQl
3o Sequencing was carried out using the
Sequenase Version 2 . O kit from US Biochemical Co.,
Cleveland, Ohio.
1 111 (O . 5 pmol) Primer, 2 111 reaction buffer,
5 ~ g) control template and 2 ~1 water were mixed
in a clean sterile vial. This was heated to 65C for
minutes and then slowly cooled to 30C. To this waS
,, _ _ _ _ _ _ _ _ . .

WO 95/15395 P~
?17~q4~ - 14-
added 1 1ll DTT (0.1 M) solution, 2 /11 extension
labelling mix (diluted 1:5), 1 l~l Mn++ buffer, 2 ,1ll
Sequenase DNA polymerase (diluted 1:8) and 0.5 ILl water
(this was replaced by 0 . 5 ~l [~35S] dATP in the
internally labelled control, this also used the
standard termination mix and not the one listed below).
This was left at room temperature for 5 minutes. 1 ~l
of a mix of all 4 dNTP's (either 30 ,Lmolar or 480
~molar solution), 1 ~11 of the relevant [~32p] ddATP
dilution (cr~nt~inin~ a range of specific activity
dilutions with a varying chemical content of 0.3, 4.8
or 48 pmoles. The ddNTP: dNTP ratio was varied
between 1:10 and 1:100) and 0.5 ~l water was added to
3 . 5 /11 of the above solution . This was incubated at
37C for 5 minute8 and then 4 ~Ll of stop dye was added
to each reaction tube. All the reaction tubes were
heated at 70-80C for 5 minutes. 4 ~11 of each reaction
was loaded onto a standard 696 polyacrylamide sequencing
gel that had been pre-run for 40 minutes. The gel was
run at 45 mA until the first dye had run off the gel,
2 hours. The gel was then dried before exposure to
film Amersham Hyperfilm MP overnight. The results
showed a much improved sequencing track with low
background and even band intensities.
Exam~le 5 Phcio~ lyL ylatlon ~f 2 ~ -deoxy~ nn~
0 . 3 mgs of 2 ' -deoxyadenosine were mixed with
3 0 units of T4 PNK and 8 nmoles of [gamma32P] ATP in
50 mM Tris-HCl pH 7 . 5, 5 mM DTT and 14 mM MgCl2 . The
3o final reaction volume was 100 ~Ll and the reaction was
incubated at 24C. The reaction was followed using
the same TLC system as in Example 1.
The results showed that the incorporation to
[32p] 5 ~ dAMP was
Time 45 minutes = 4%
Time 240 minutes = 15%
Overnight = 4496
.. _ . .... . . , . . . _

WogS/15395 2 ~ 74'~42 P~-. Lr? ~n
- 15 -
r l e ~ ~Th; . ..,h-. r,hG Yl8~ n)
3 .5 /lmoles of 2 ', 3 ' -dideoxyadenosine,
adenosine and 2 ~ deoxyadenosine were individually mixed
with 150 units 3 ' phosphatase free PNK and 85 pmoles of
J 5 [gamma35S] ATP in a buffer -nnt:~in.n~ 50 mM Tris-HCl pH
7.5, 2.5 mM DTT, 20 mM Mg Acetate, 0.1 mM Spermine and
0.5 mM NH4Cl. The final reaction volumes were 100
and the re~r~ n~ were incubated at 18C. The
reactions were followed by TLC analysis on PEI
cellulose plates developed in 0 . 5 M LiCl and 1 M formic
acid .
After a 21 hour incubation the reactions
cnnt ~ i nf~d
8 . 3~6 Adeno8ine-5 ' -monothiophosphate [35S]
11.2~ 2'-deoxyadenosine-5'-monothiophosphate [35S]
2 . 8~ 2 ', 3 ~ -dideoxyadenosine-5 ~ -
monothiophosphate [35S]
Exa~l:21e 7 (Modified Suqar~
3 . 5 ~moles of 3 ' -azidothymidine was mixed
with 50 units 3 ~ phosphatase free PNK and 5 nmoles of
[gamma32P] ATP in a buffer cnnt~in;n~ 50 mM Tris-HCl pH
7.5, 2.5 mM DTT, 20 mM Mg Acetate, 0.1 mM Spermine and
0.5 mM NH4Cl. The final reaction volume was 100 ~Ll and
the reaction was incubated at 18C. The reaction was
followed by TLC analysis on PEI cellulose plates
developed in 0 . 5 M LiCl and 1 M f ormic acid .
After a 3 hour incubation the reaction
contained 22?~ 3 ~ -azidothymidine-5 ' -monophosphate [32p],
3o
Exale 8 ~Base Modifica~ n~)
3.5 ~Lmoles of 7-rl~7~1Pn~c;n~ (tubercidin),
3-nitropyrole nucleoside and 5-nitroindole nucleoside
(ref: D Loakes and D M Brown, NAR, 1994 , Vol . 22 , No .
35 20, pg 4039-4043) were individually mixed with 50 units

WO95/15395 P( ~
~ ~ 4~ L~
- 16 -
3 ' phosphatase free PNK and 5 nmoles of [gamma32P] ATP
in a buffer ~L~t~;nin~ 50 mM Tris-XCl pH 7.5, 2.5 mM
DTT, 20 mM Mg Acetate, 0.1 mM Spermine and 0.5 mM
NH4Cl. The final reaction volumes were 100 ~l and the
5 reactions were incubated at 18C. The reactions were
followed by TLC analysis on PEI cellulose plates
developed in 0.5 M LiCl and 1 M formic acid.
After a 3 hour incubation additional peaks
were observed on the TLC scans. These were presumably
10 due to the substrate as they were not ~een in the
absence of substrate.
63 . O~s 7~ 7~1L~nnsine-5 ~ -monophosphate [32p] *
16.1~6 3-nitropyrolenucleoside-5 ' -
rc~nL~ph--sphate [32p] *
23.996 5-nitroindolenucleoside-5'-
monophosphate [ 3 2 p ] *
~ The6e products were only seen in the
presence o~ the substrate and were not seen in the
control experiments without substrate.
Exale 9
3 . 5 ~moles of each 2 ', 3 ' -dideoxynucleoside
(all four bases) were individually mixed with 1000
units 3 'phosphatase free PNK and 60 to 100 mCi of
[gamma33P~ ATP (at ~3000 Ci/mmole) in a buffer
containing 50 mM Tris-HCl pH 7A5~ 2.5 mM DTT, 20 mM Mg
acetate, 150 mM NaCl, 0.1 mM spermine and 0.5 mM NH4Cl.
The f inal reaction volumes were 2 ml and the reactions
were incubated at 18C from 2 to 6 hours. The
3o reactions were followed by TLC analysis on PEI
cellulose plates developed in 0 . 5 M LiCl and 1 M f ormic
acid .
The reactions were stopped by the addition of
2 ml absolute ethanol. After filtration the reactions
were purified by HPLC ion-exchange chromatography. TLC
analysis of the purified monophosphates showed that the

WO95/15395 2 ~ ~4942 r~l~v~ 1'?7~C~0
-- 17 -
[33P]ddAMP cl~nt~;n~l some inorganic 33P04. The other
three monophosphate5 all had purities in excess of 909~.
The yields of the reactions were of the same order as
those seen in the small scale assays in Table 1.
The [33P] ddNMP ' 8 were converted to the
respective [a33P~ ddNTP's readily and efficiently by
standard method8.
Af ter purif ication by HPLC ion exchange
chromatography the [a33P] ddNTP's were resuspended at
10 -4 mCi/ml in aqueous solution. The final yields from
[gamma33P] ATP were:
ddATP 4
ddCTP 3 0 ~
ddGTP 2 0 96
ddTTP 169~
Samples were taken for identification by
analytical HPLC against the respective non-radioactive
ddNTP marker and f or use in DNA sequencing . The
results showed that with all ddNTP ' 8 the radiolabelled
[a33P] ddNTP and the non-radioactive ddNTP eluted from
the HPLC column at exactly the same time.
r le lD Se~l~n~~;n~ DN~
Using the methods outlined in Examples 1-3,
[a-32P] ddGTP, [a-32P] ddATP, [a-32P] ddTTP and [a-
32p] ddCTP were prepared with a specific activity of
approxi~nately 2000 Ci/mmol and concentration of 0.5 ~M.
These were used in the following fashion to determine
the base sequence of M13mpl8 DNA. Many of the reagents
described here can be found in the Sequenase DNA
sequencing kits produced by US Biochemical Co.,
Cleveland, Ohio.
Four nucleotide termination mixes were
prepared by mixing 2 1ll of 15 ~LM dATP, dTTP, dCTP, dGTP
and 100 mM NaCl with 0.6 /11 (c~nt~;n;n~ 0.3 pmol) of
each of the radiolabelled ddNTP solutions.
_

Wo 95115395 1
749~2 _ 18 -
Template DNA ~Ml3mpl~, l.0 ~g in 5 ~Ll) was
mixed with 0.5 pmol (l Ill) of Ml3 "-40" 23-mer
oligonucleotide primer, 1 Ill of MOPS buffer (400 mM
morpholinopropanesulphonic acid-NaOH, pH 7.5, 500
mM NaCl, l00 mM MgCl2, l ~l of Mn buffer, 50 mM MnCl2,
150 mM Isocitrate, sodium salt) and 2 ~Ll of water for a
total volume of l0 Ill. This mixture was warmed to 37C
for l0 min to anneal the primer to the template. The
mixture was chilled on ice and 1 ~Ll of 0 . l M
dithiothreitol and 2 ~l of polymerase mixture (1.6
Units/~l Sequenase Version 2 . 0 T7 DNA polymerase (US
Biochemical Corp. ), 2 . 0 Units/ml inorganic
pyrophosphotase 20 mM Tris.HCl pH 7.5, 2 mM DTT 0.l mM
EDTA, 5096 Glycerol) added and mixed well. Then 3 ~ll
portion of this DNA and poIymerase mixture were mixed
with the pre-warmed (to 37C) termination mixtures
2 . 6 Ill ) described above . The mixtures were allowed to
incubate for l0 min at 37C, then 4 /ll of stop solution
(95$ Formamide 20 mM EDTA 0.05$ BL~ ~hPn~l Blue 0.05
Xylene Cyanol FF) were added to stop the reaction.
The mixtures were heated briefly and applied
to a denaturing polyacrylamide electrophoresis gel
buffered with Tris-taurine-EDTA buffer (US 5,134, 595,
Pisa-Williamson, D. & Fuller, C. W. (1992) ~ R
l9, 29-36). After electrophoresis, the gel was dried
by standard procedures and exposed to f ilm overnight .
The resulting DNA sequencing autoradiogram was
exceptionally free of background, clearly showed the
identity of the first nucleotide added to the 3 ' end of
the primer, had uniform band intensities.
r 1 ,- ll Se~ in~ V~3ina rlTlrP to R~ n~te
n Artifact~ - ~
Compression artifacts occur when the DNA
being separated on a sequencing electrophoresis gel are
not completely denatured. Nucleotide analogues such as
. _ , _ _ _, ~, , . ,, .. . , _ _ _ _ _ . . ,

Wo 95r~s395 2 1 7 4 9 4 2 r~~ n?~
- 19 -
dITP (deoxyinosine triphosphate) which replace dGTP in
the sequencing reactions can f~l ;min~te compression
artifacts (Tabor. S. and Richardson, C. C. (1987) Proc.
Nat. Acad. Sci. USA 84, 4767-4771). Sequencing
5 reactions were run exactly as described in Example 10
except that the four nucleotide termination mixes were
prepared by mixing 2 /11 of 75 ~lM dITP, 15 ~M dATP,
dTTP, dCTP and 100 mM NaCl with 0.6 ~ nt~;nin~
0 . 3 pmol ) of each of the radiolabelled ddNTP solutions .
10 Sequencing of M13mpl8 template DNA was done using a
different primer chosen to sequence through a region
prone to compression artifacts. When the dITP-
containing mixture was used, no compression artifacts
were observed while control sequences run with dGTP
15 mixtures did have compressed, unreadable regions.

Representative Drawing

Sorry, the representative drawing for patent document number 2174942 was not found.

Administrative Status

2024-08-01:As part of the Next Generation Patents (NGP) transition, the Canadian Patents Database (CPD) now contains a more detailed Event History, which replicates the Event Log of our new back-office solution.

Please note that "Inactive:" events refers to events no longer in use in our new back-office solution.

For a clearer understanding of the status of the application/patent presented on this page, the site Disclaimer , as well as the definitions for Patent , Event History , Maintenance Fee  and Payment History  should be consulted.

Event History

Description Date
Inactive: IPC expired 2018-01-01
Application Not Reinstated by Deadline 2005-12-01
Time Limit for Reversal Expired 2005-12-01
Deemed Abandoned - Failure to Respond to Maintenance Fee Notice 2004-12-01
Inactive: Status info is complete as of Log entry date 2001-12-18
Inactive: Application prosecuted on TS as of Log entry date 2001-12-18
Letter Sent 2001-12-18
Request for Examination Requirements Determined Compliant 2001-11-27
All Requirements for Examination Determined Compliant 2001-11-27
Amendment Received - Voluntary Amendment 1996-04-24
Application Published (Open to Public Inspection) 1995-06-08

Abandonment History

Abandonment Date Reason Reinstatement Date
2004-12-01

Maintenance Fee

The last payment was received on 2003-11-18

Note : If the full payment has not been received on or before the date indicated, a further fee may be required which may be one of the following

  • the reinstatement fee;
  • the late payment fee; or
  • additional fee to reverse deemed expiry.

Patent fees are adjusted on the 1st of January every year. The amounts above are the current amounts if received by December 31 of the current year.
Please refer to the CIPO Patent Fees web page to see all current fee amounts.

Fee History

Fee Type Anniversary Year Due Date Paid Date
MF (application, 3rd anniv.) - standard 03 1997-12-01 1997-11-18
MF (application, 4th anniv.) - standard 04 1998-12-01 1998-11-17
MF (application, 5th anniv.) - standard 05 1999-12-01 1999-11-16
MF (application, 6th anniv.) - standard 06 2000-12-01 2000-11-24
MF (application, 7th anniv.) - standard 07 2001-12-03 2001-11-19
Request for examination - standard 2001-11-27
MF (application, 8th anniv.) - standard 08 2002-12-02 2002-11-18
MF (application, 9th anniv.) - standard 09 2003-12-01 2003-11-18
Owners on Record

Note: Records showing the ownership history in alphabetical order.

Current Owners on Record
AMERSHAM INTERNATIONAL PLC
Past Owners on Record
CARL FULLER
CLIFFORD SMITH
Past Owners that do not appear in the "Owners on Record" listing will appear in other documentation within the application.
Documents

To view selected files, please enter reCAPTCHA code :



To view images, click a link in the Document Description column. To download the documents, select one or more checkboxes in the first column and then click the "Download Selected in PDF format (Zip Archive)" or the "Download Selected as Single PDF" button.

List of published and non-published patent-specific documents on the CPD .

If you have any difficulty accessing content, you can call the Client Service Centre at 1-866-997-1936 or send them an e-mail at CIPO Client Service Centre.


Document
Description 
Date
(yyyy-mm-dd) 
Number of pages   Size of Image (KB) 
Claims 1995-06-07 3 84
Abstract 1995-06-07 1 42
Description 1995-06-07 19 752
Description 2002-01-20 19 895
Claims 2002-01-20 2 95
Reminder - Request for Examination 2001-08-01 1 118
Acknowledgement of Request for Examination 2001-12-17 1 179
Courtesy - Abandonment Letter (Maintenance Fee) 2005-01-25 1 175
PCT 1996-04-23 17 646
Fees 1996-11-18 1 88